Loading...
XSWX
ALC
Market cap39bUSD
Dec 04, Last price  
63.44CHF
1D
-0.72%
1Q
-1.00%
IPO
10.06%
Name

Alcon AG

Chart & Performance

D1W1MN
XSWX:ALC chart
P/E
38.35
P/S
3.94
EPS
2.06
Div Yield, %
0.76%
Shrs. gr., 5y
0.38%
Rev. gr., 5y
5.71%
Revenues
9.91b
+4.82%
6,517,955,3426,596,000,0006,792,000,0007,153,000,0007,508,000,0006,833,000,0008,291,000,0008,717,000,0009,455,000,0009,911,000,000
Net income
1.02b
+4.52%
296,270,697-170,000,000256,000,000-227,000,000-656,000,000-531,000,000376,000,000335,000,000974,000,0001,018,000,000
CFO
2.08b
+40.20%
1,317,827,4521,245,000,0001,218,000,0001,140,000,000920,000,000823,000,0001,345,000,0001,217,000,0001,481,502,1072,077,000,000
Dividend
May 14, 20240.24 CHF/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
IPO date
Apr 09, 2019
Employees
25,000
Domiciled in
CH
Incorporated in
CH

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT